Combined inhibition of 20-hydroxyeicosatetraenoic acid synthesis and soluble epoxide hydrolase attenuates the development of hypertension in Ren-2 transgenic rats

被引：0
|
作者：
Certikova, V
Kramer, HJ
Tesar, V
Bader, M
Ganten, D
Imig, JD
Falck, JR
Hammock, BD
Vaneckova, I
Cervenka, L
机构：
[1] Charles Univ, Dept Nephrol, Prague, Czech Republic
[2] Univ Bonn, Nephrol Sect, D-5300 Bonn, Germany
[3] Max Delbruck Ctr Mol Med, Berlin, Germany
[4] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA
[5] Ctr Med Expt, Prague, Czech Republic
来源：
HYPERTENSION | 2004年 / 44卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PG01
引用
收藏
页码：584 / 584
页数：1
相关论文
共 50 条
  • [31] Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease
    Chabova, Vera Certikova
    Kujal, Petr
    Skaroupkova, Petra
    Varnourkova, Zdenka
    Vackova, Sarka
    Huskova, Zuzana
    Kikerlova, Sona
    Sadowski, Janusz
    Kompanowska-Jezierska, Elzbieta
    Baranowska, Iwona
    Hwang, Sung Hee
    Hammock, Bruce D.
    Imig, John D.
    Tesar, Vladimir
    Cervenka, Ludek
    KIDNEY & BLOOD PRESSURE RESEARCH, 2018, 43 (02): : 329 - 349
  • [32] Effects of sodium restriction and cyclooxygenase-2 inhibition on the course of hypertension, proteinuria and cardiac hypertrophy in Ren-2 transgenic rats
    Vanecková, I
    Skaroupková, P
    Dvorák, P
    Chábová, VC
    Tesar, V
    Bader, M
    Ganten, D
    Kramer, HJ
    PHYSIOLOGICAL RESEARCH, 2005, 54 (01) : 17 - 24
  • [33] Androgen receptor deficiency attenuates hypertension and end-organ damage in transgenic rats harboring the mouse Ren-2 gene
    Baltatu, O
    Cayla, C
    Jordan, C
    Andreev, D
    Bader, M
    HYPERTENSION, 2000, 36 (04) : 671 - 671
  • [34] Endogenous androgen exaggerates hypertension in spontaneously hypertensive rats through CYP4A2 and 20-hydroxyeicosatetraenoic acid
    Ito, Osamu
    Ishizuka, Tsuneo
    Yoneki, Yoshiko
    Mori, Takefumi
    Muroya, Yoshikazu
    Ito, Daisuke
    Omata, Ken
    Ito, Sadayoshi
    Kohzuki, Masahiro
    ENDOCRINE JOURNAL, 2010, 57 : S574 - S574
  • [35] Effect of Angiotensin-Converting Enzyme Blockade, Alone or Combined With Blockade of Soluble Epoxide Hydrolase, on the Course of Congestive Heart Failure and Occurrence of Renal Dysfunction in Ren-2 Transgenic Hypertensive Rats With Aorto-Caval Fistula
    Kala, P.
    Sedlakova, L.
    Skaroupkova, P.
    Kopkan, L.
    Vanourkova, Z.
    Taborsky, M.
    Nishiyama, A.
    Hwang, S. H.
    Hammock, B. D.
    Sadowski, J.
    Melenovsky, V
    Imig, J. D.
    Cervenka, L.
    PHYSIOLOGICAL RESEARCH, 2018, 67 (03) : 401 - 415
  • [36] Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats
    Kopkan, Libor
    Huskova, Zuzana
    Vanourkova, Zdenka
    Thumova, Monika
    Skaroupkova, Petra
    Maly, Jan
    Kramer, Herbert J.
    Dvorak, Pavel
    Cervenka, Ludek
    VASCULAR PHARMACOLOGY, 2009, 51 (2-3) : 175 - 181
  • [37] Renal functional responses to selective intrarenal 20-hydroeicosatetraenoic acid and epoxyeicosatrienoic acids in hypertensive Ren-2 transgenic rats
    Vanècková, I
    èertíková, V
    Kramer, HJ
    Tesar, V
    Imig, JD
    Falck, JR
    Bader, M
    Ganten, D
    Cervenka, L
    HYPERTENSION, 2004, 44 (04) : 550 - 550
  • [38] Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats
    Chabova, Vera Certikova
    Kramer, Herbert J.
    Vaneckova, Ivana
    Vernerova, Zdena
    Eis, Vaclav
    Tesar, Vladimir
    Skaroupkova, Petra
    Thumova, Monika
    Schejbalova, Stanislava
    Huskova, Zuzana
    Vanourkova, Zdenka
    Kolsky, Alexander
    Imig, John D.
    Cervenka, Ludek
    VASCULAR PHARMACOLOGY, 2007, 47 (2-3) : 145 - 159
  • [39] Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: Studies in Cyp1a1-Ren-2 transgenic rats
    Sporkova, Alexandra
    Jichova, Sarka
    Huskova, Zuzana
    Kopkan, Libor
    Nishiyama, Akira
    Hwang, Sung H.
    Hammock, Bruce D.
    Imig, John D.
    Kompanowska-Jezierska, Elzbieta
    Sadowski, Janusz
    Kramer, Herbert J.
    Cervenka, Ludek
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2014, 41 (12) : 1003 - 1013
  • [40] The renin-angiotensin system (RAS) plays no role in the development of sexual dimorphism of hypertension in heterozygous Ren-2 renin transgenic rats
    Vanourkova, Zdenka
    Kramer, Herbert
    Kopkan, Libor
    Huskova, Zuzana
    Vaneckova, Ivana
    Cervenka, Ludek
    Mullins, John
    HYPERTENSION, 2007, 50 (04) : E109 - E109
12345